Skip to content
★ Sign in to follow
BP
Total declarations
33
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€1.5M

Latest filing published 01 Sept 2017 for CYTOKINETICS INC, €93k.

Filing timeline

BuySale
Bradley Paul Morgan

Insider track record

Disclosed buys
0
Disclosed sells
15
Signal history

Bradley Paul Morgan: trading record in brief

Bradley Paul Morgan discloses dealings in Cytokinetics Inc to SEC (Form 4). The record holds 33 filings, for trades running from 28 February 2017 to 31 August 2017.

Every open-market trade on record is a sale: 15 sales worth €1.5M. Outside the open market, there are 3 share grants and 15 option exercises.

Most recently, on 1 September 2017, the filings show an option exercise worth €93k in Cytokinetics Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Bradley Paul Morgan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations33 total
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    111,162 USD11SEC
    16,666 shares@ US$6.674.0% of flowCommon StockSEC:0001061983-17-000052:0
  • ▼
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    249,990 USD30SEC
    16,666 shares@ US$15.009.0% of flowCommon StockSEC:0001061983-17-000052:1
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    121,040 USD11SEC
    15,206 shares@ US$7.964.4% of flowCommon StockSEC:0001061983-17-000052:2
  • ▼
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    228,090 USD30SEC
    15,206 shares@ US$15.008.2% of flowCommon StockSEC:0001061983-17-000052:3
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    18,260 USD11SEC
    2,294 shares@ US$7.960.7% of flowCommon StockSEC:0001061983-17-000052:4
  • ▼
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    34,410 USD29SEC
    2,294 shares@ US$15.001.2% of flowCommon StockSEC:0001061983-17-000052:5
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    111,477 USD11SEC
    11,552 shares@ US$9.654.0% of flowCommon StockSEC:0001061983-17-000052:6
  • ▼
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    173,280 USD30SEC
    11,552 shares@ US$15.006.2% of flowCommon StockSEC:0001061983-17-000052:7
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    129,773 USD11SEC
    13,448 shares@ US$9.654.7% of flowCommon StockSEC:0001061983-17-000052:8
  • ▼
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    201,720 USD30SEC
    13,448 shares@ US$15.007.3% of flowCommon StockSEC:0001061983-17-000052:9
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    22,770 USD11SEC
    3,795 shares@ US$6.000.8% of flowCommon StockSEC:0001061983-17-000052:10
  • ▼
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    56,925 USD29SEC
    3,795 shares@ US$15.002.1% of flowCommon StockSEC:0001061983-17-000052:11
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    127,224 USD11SEC
    21,204 shares@ US$6.004.6% of flowCommon StockSEC:0001061983-17-000052:12
  • ▼
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    318,060 USD30SEC
    21,204 shares@ US$15.0011.5% of flowCommon StockSEC:0001061983-17-000052:13
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    6,798 USD11SEC
    1,079 shares@ US$6.300.2% of flowCommon StockSEC:0001061983-17-000052:14
  • ▼
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    16,185 USD29SEC
    1,079 shares@ US$15.000.6% of flowCommon StockSEC:0001061983-17-000052:15
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    87,696 USD11SEC
    13,920 shares@ US$6.303.2% of flowCommon StockSEC:0001061983-17-000052:16
  • ▼
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    208,800 USD30SEC
    13,920 shares@ US$15.007.5% of flowCommon StockSEC:0001061983-17-000052:17
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    5,812 USD11SEC
    617 shares@ US$9.420.2% of flowCommon StockSEC:0001061983-17-000052:18
  • ▼
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    9,255 USD29SEC
    617 shares@ US$15.000.3% of flowCommon StockSEC:0001061983-17-000052:19
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    111,938 USD11SEC
    11,883 shares@ US$9.424.0% of flowCommon StockSEC:0001061983-17-000052:20
  • ▼
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    178,245 USD30SEC
    11,883 shares@ US$15.006.4% of flowCommon StockSEC:0001061983-17-000052:21
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    7,703 USD11SEC
    694 shares@ US$11.100.3% of flowCommon StockSEC:0001061983-17-000052:22
  • ▼
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    10,410 USD29SEC
    694 shares@ US$15.000.4% of flowCommon StockSEC:0001061983-17-000052:23
  • ◇
    SVP Drug Discovery & Early DevExecutivesCytokinetics Inc
    29,293 USD11SEC
    2,639 shares@ US$11.101.1% of flowCommon StockSEC:0001061983-17-000052:24

25 of 33 declarations